These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27272500)

  • 1. Using the cognitive assessment interview to screen cognitive impairment in psychosis.
    Sánchez-Torres AM; Elosúa MR; Lorente-Omeñaca R; Moreno-Izco L; Peralta V; Ventura J; Cuesta MJ
    Eur Arch Psychiatry Clin Neurosci; 2016 Oct; 266(7):629-37. PubMed ID: 27272500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Cognitive Assessment Interview: A comparative study in first episode and chronic patients with psychosis.
    Sánchez-Torres AM; Elosúa MR; Lorente-Omeñaca R; Moreno-Izco L; Peralta V; Cuesta MJ
    Schizophr Res; 2016 Dec; 178(1-3):80-85. PubMed ID: 27617413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of cognitive impairment in psychosis spectrum disorders through self-reported and interview-based measures.
    Sánchez-Torres AM; Moreno-Izco L; Gil-Berrozpe GJ; Lorente-Omeñaca R; Zandio M; Zarzuela A; Peralta V; Cuesta MJ
    Eur Arch Psychiatry Clin Neurosci; 2022 Oct; 272(7):1183-1192. PubMed ID: 35362774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive Assessment Interview (CAI): Validity as a co-primary measure of cognition across phases of schizophrenia.
    Ventura J; Subotnik KL; Ered A; Hellemann GS; Nuechterlein KH
    Schizophr Res; 2016 Apr; 172(1-3):137-42. PubMed ID: 26852403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Cognitive Assessment Interview (CAI): reliability and validity of a brief interview-based measure of cognition.
    Ventura J; Reise SP; Keefe RS; Hurford IM; Wood RC; Bilder RM
    Schizophr Bull; 2013 May; 39(3):583-91. PubMed ID: 22328641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and validation of a brief scale for cognitive evaluation in people with a diagnosis of schizophrenia (BCog-S).
    Sánchez-Martínez V; Sales-Orts R
    J Psychiatr Ment Health Nurs; 2020 Oct; 27(5):543-552. PubMed ID: 31976597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for cognitive impairment in non-affective psychoses: A comparison between the SCIP and the MoCA.
    Belvederi Murri M; Folesani F; Costa S; Biancosino B; Colla C; Zerbinati L; Caruso R; Nanni MG; Purdon SE; Grassi L
    Schizophr Res; 2020 Apr; 218():188-194. PubMed ID: 31948897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Cognitive Assessment Interview (CAI): Association with neuropsychological scores and real-life functioning in a large sample of Italian subjects with schizophrenia.
    Giordano GM; Palumbo D; Mucci A; Ventura J; Giuliani L; Perrottelli A; Bucci P; Rocca P; Rossi A; Bertolino A; Rucci P; Galderisi S; Maj M;
    Schizophr Res; 2022 Mar; 241():161-170. PubMed ID: 35124435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S): psychometric properties of a brief scale for cognitive evaluation in schizophrenia.
    Pino O; Guilera G; Rojo JE; Gómez-Benito J; Bernardo M; Crespo-Facorro B; Cuesta MJ; Franco M; Martinez-Aran A; Segarra N; Tabarés-Seisdedos R; Vieta E; Purdon SE; Díez T; Rejas J;
    Schizophr Res; 2008 Feb; 99(1-3):139-48. PubMed ID: 17959358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Cognitive Assessment Interview (CAI): development and validation of an empirically derived, brief interview-based measure of cognition.
    Ventura J; Reise SP; Keefe RS; Baade LE; Gold JM; Green MF; Kern RS; Mesholam-Gately R; Nuechterlein KH; Seidman LJ; Bilder RM
    Schizophr Res; 2010 Aug; 121(1-3):24-31. PubMed ID: 20542412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity.
    Keefe RS; Poe M; Walker TM; Kang JW; Harvey PD
    Am J Psychiatry; 2006 Mar; 163(3):426-32. PubMed ID: 16513863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief cognitive assessment instruments in schizophrenia and bipolar patients, and healthy control subjects: a comparison study between the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS) and the Screen for Cognitive Impairment in Psychiatry (SCIP).
    Cuesta MJ; Pino O; Guilera G; Rojo JE; Gómez-Benito J; Purdon SE; Franco M; Martínez-Arán A; Segarra N; Tabarés-Seisdedos R; Vieta E; Bernardo M; Crespo-Facorro B; Mesa F; Rejas J
    Schizophr Res; 2011 Aug; 130(1-3):137-42. PubMed ID: 21652178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interview-based assessment of cognition in schizophrenia: applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care.
    Vita A; Deste G; Barlati S; De Peri L; Giambra A; Poli R; Keefe RS; Sacchetti E
    Schizophr Res; 2013 May; 146(1-3):217-23. PubMed ID: 23510596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Persian version of the Schizophrenia Cognition Rating Scale (SCoRS) in patients with schizophrenia.
    Mazhari S; Ghafaree-Nejad AR; Soleymani-Zade S; Keefe RSE
    Asian J Psychiatr; 2017 Jun; 27():12-15. PubMed ID: 28558882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity and utility of a set of clinical criteria for cognitive impairment associated with psychosis (CIAPs).
    Cuesta MJ; Sánchez-Torres AM; Lorente-Omeñaca R; Zandio M; Moreno-Izco L; Peralta V
    Psychiatry Res; 2020 Nov; 293():113404. PubMed ID: 32911349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The screen for cognitive impairment in psychiatry (SCIP) is associated with disease severity and cognitive complaints in major depression.
    Tourjman SV; Juster RP; Purdon S; Stip E; Kouassi E; Potvin S
    Int J Psychiatry Clin Pract; 2019 Mar; 23(1):49-56. PubMed ID: 29553848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Interview-Based Assessment of the Experience of Cognitive Impairment in Multiple Sclerosis: The Cognitive Assessment Interview (CAI).
    Eilam-Stock T; Best P; Sherman K; Shaw MT; Ventura J; Krupp LB; Charvet LE
    Front Neurol; 2021; 12():637895. PubMed ID: 33643211
    [No Abstract]   [Full Text] [Related]  

  • 19. The Experience of Cognitive Impairment in People with Psychosis.
    Wood H; Cupitt C; Lavender T
    Clin Psychol Psychother; 2015; 22(3):193-207. PubMed ID: 24281753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying attentional deficits in people with first-episode psychosis with the Scale for the Assessment of Negative Symptoms attention subscale: is it possible?
    González-Blanch C; Priede A; Rodríguez-Sánchez JM; Perez-Iglesias R; Vázquez-Barquero JL; Crespo-Facorro B
    Compr Psychiatry; 2012 Aug; 53(6):701-5. PubMed ID: 22206803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.